A retrospective cohort study on the treatment outcomes and genotyping of isoniazid-resistant tuberculosis patients in Eastern China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A retrospective cohort study on the treatment outcomes and genotyping of isoniazid-resistant tuberculosis patients in Eastern China

Published:2022-09 Issue: Volume:30 Page:335-339
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Li Yishu,Shi Jinyan,Song Wenlei,Shao Yan,Zhu Limei,Chen Cheng

Funder

SAS Institute

Jiangsu Commission of Health

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference25 articles.

1. Global tuberculosis report 2020,2020

2. Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014;Karo;Euro Surveill,2019

3. Role of individual drugs in the chemotherapy of tuberculosis;Mitchison;Int J Tuberc Lung Dis,2000

4. Isoniazid for preventing tuberculosis in non-HIV infected persons;Smieja;Cochrane Database Syst Rev,2000

5. WHO treatment guidelines for isoniazid-resistant tuberculosis: supplement to the WHO treatment guidelines for drug-resistant tuberculosis;World Health Organization,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors of adult isoniazid-resistant and rifampicin-susceptible tuberculosis in Nanjing, 2019–2021;BMC Infectious Diseases;2024-05-22

2. Side effects of drugs used in the treatment of tuberculosis and leprosy;Side Effects of Drugs Annual;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP